Over 2 billion people around the globe have impairments that affect their ability to see. One billion of those people have issues that could have been prevented.
Category: pharma & healthcare
Wastewater Analysis Update On BA.2.86 In The United States: It’s Here, Be Careful
The latest iteration of Omicron, BA.2.86, is here, and we must be ready for its arrival.
What To Know About The New RSV Vaccines
Three new RSV vaccines and one new monoclonal antibody RSV treatment for infants have been approved by the FDA as we approach peak season for the virus.
What To Know About The New RSV Vaccines
Three new RSV vaccines and one new monoclonal antibody RSV treatment for infants have been approved by the FDA as we approach peak season for the virus.
Covid-19: The Shapeshifting Protean Virus
A new variant of SARS-CoV-2, BA.2.86, may spark the latest wave of Covid-19.
Covid-19: The Shapeshifting Protean Virus
A new variant of SARS-CoV-2, BA.2.86, may spark the latest wave of Covid-19.
How mRNA Could Safely Replace Blood Stem Cell Transplantation
A preclinical study published in Science offers a compelling avenue for future research to enhance or replace current stem cell transplantations altogether.
Latest Covid Wave Driven By Eris (EG.5), But Pirola (BA.2.86) Is Waiting In The Wings
just as the world may be getting used to seeing Eris (EG.5) gain steam, BA.2.86, dubbed Pirola, may be hot on its heels as the next concerning sub-variant of Omicron.
Induced Pluripotent Stem Cells For Age-Related Macular Degeneration
Induced pluripotent stem cells show great promise for age-related macular degeneration, as revealed by recent research published in the New England Journal of Medicine.
Nearly Half Of Americans Polled Want Weight Loss Drugs But Many Lose Interest After Reading The Fine Print
While the market for weight loss drugs has potential, questions are raised concerning the drugs’ route of administration, side effect profile, cost and lack of coverage.
